celecoxib has been researched along with Metaplasia in 6 studies
Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test whether the chronic users of celecoxib, a selective cyclo-oxygenase-2 inhibitor, had less Helicobacter pylori-related intestinal metaplasia or if such users' intestinal metaplasia could be prone to disappear after H." | 7.74 | Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. ( Cheng, HC; Hung, KH; Liou, MF; Sheu, BS; Wu, JJ; Yang, HB, 2007) |
| "To test whether the chronic users of celecoxib, a selective cyclo-oxygenase-2 inhibitor, had less Helicobacter pylori-related intestinal metaplasia or if such users' intestinal metaplasia could be prone to disappear after H." | 3.74 | Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. ( Cheng, HC; Hung, KH; Liou, MF; Sheu, BS; Wu, JJ; Yang, HB, 2007) |
| "A series of 90 rats underwent a duodenoesophageal reflux surgery were divided into 2 groups: the control group was given a commercial chow and the celecoxib group experimental chow containing celecoxib." | 3.73 | [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats]. ( Fujimura, T; Miwa, K; Oyama, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colby, JK | 1 |
| Klein, RD | 1 |
| McArthur, MJ | 1 |
| Conti, CJ | 1 |
| Kiguchi, K | 1 |
| Kawamoto, T | 1 |
| Riggs, PK | 1 |
| Pavone, AI | 1 |
| Sawicki, J | 1 |
| Fischer, SM | 1 |
| Hung, KH | 2 |
| Yang, HB | 3 |
| Cheng, HC | 3 |
| Wu, JJ | 2 |
| Sheu, BS | 3 |
| Tsai, YC | 1 |
| Wu, CT | 1 |
| Chang, WL | 1 |
| Miwa, K | 1 |
| Oyama, K | 1 |
| Fujimura, T | 1 |
| Liou, MF | 1 |
| Futagami, S | 1 |
| Suzuki, K | 1 |
| Hiratsuka, T | 1 |
| Shindo, T | 1 |
| Hamamoto, T | 1 |
| Ueki, N | 1 |
| Kusunoki, M | 1 |
| Miyake, K | 1 |
| Gudis, K | 1 |
| Tsukui, T | 1 |
| Sakamoto, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.[NCT05544396] | 100 participants (Anticipated) | Interventional | 2023-11-08 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for celecoxib and Metaplasia
| Article | Year |
|---|---|
Chemopreventive effect of celecoxib in gastric cancer.
Topics: Animals; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gastric | 2007 |
2 trials available for celecoxib and Metaplasia
| Article | Year |
|---|---|
Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
Topics: Aged; Atrophy; beta Catenin; Biomarkers; Blood Urea Nitrogen; Celecoxib; Creatinine; Cyclooxygenase | 2010 |
Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication.
Topics: Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Gastritis, Atrophic; Helicobacter Infections; | 2013 |
3 other studies available for celecoxib and Metaplasia
| Article | Year |
|---|---|
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Celecoxib; Cell Transformation, Neoplastic | 2008 |
[A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
Topics: Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 | 2005 |
Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Dyspepsia; Female; Gastric Mucosa; Helicobacter Infections; He | 2007 |